FDA Form 483 Krystal Biotech Inc., Pittsburgh, PA Jan 2025

Form 483 issued January 30, 2025 · Pittsburgh, Pennsylvania

Observations
2
Pages
4

In short: On January 30, 2025, FDA issued a Form 483 with 2 observations to FDA Form 483 Krystal Biotech Inc., Pittsburgh, PA Jan 2025 in Pittsburgh, Pennsylvania. The investigators were Lewis K. Antwi and Richard L. Bartlett. Most observations concern quality system and materials; the most-cited regulation is 21 CFR 211.192 (production record review).

At a glance

Quality system and materials account for 2 of 2 observations.

Quality system1
Materials1

Most cited: 21 CFR 211.192 (1×) · 211.84 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    There is a failure to thoroughly review any unexplained discrepancy whether or not the batch has…

  2. 02

    Observation 2: scanned text, readable in the full document.

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at FDA Form 483 Krystal Biotech Inc., Pittsburgh, PA Jan 2025?

FDA listed 2 observations on this Form 483, mostly about quality system and materials. The most-cited regulation is 21 CFR 211.192 (production record review). The opening words of each observation are shown on this page.

Who inspected FDA Form 483 Krystal Biotech Inc., Pittsburgh, PA Jan 2025?

Lewis K. Antwi and Richard L. Bartlett are named on this Form 483. Each investigator has a profile showing what they cite most.

When was FDA Form 483 Krystal Biotech Inc., Pittsburgh, PA Jan 2025 inspected by FDA?

This Form 483 is dated January 30, 2025.

How do I get the full Form 483 for FDA Form 483 Krystal Biotech Inc., Pittsburgh, PA Jan 2025?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free